Table 3 Relationship between outcome (28-day survival) and various factors using the enter method of logistic regression analysis

AT dose:

3,000 versus 1,500 IU

2.414

0.025

1.115-5.226

Gender

0.746

0.296

0.432-1.291

Age

0.977

0.045

0.955-0.999

Body weight

0.998

0.901

0.974-1.023

Baseline AT activity

1.004

0.822

0.969-1.041

Baseline DIC score

0.875

0.198

0.714-1.072

Heparin

0.808

0.499

0.435-1.500

Recombinant thrombomodulin

3.639

0.057

0.960-13.790

Baseline platelet count

1.054

0.027

1.006-1.104

Respiratory tract infection

0.632

0.492

0.170-2.343

Digestive tract infection

1.034

0.960

0.279-3.832

Urinary tract infection

3.019

0.140

0.695-13.115

Biliary tract infection

1.208

0.791

0.300-4.871

Other infection

0.799

0.772

0.175-3.640

Unknown infection focus

0.901

0.891

0.203-3.995

Surgery

0.929

0.818

0.498-1.733